BMCAX
Price
$23.58
Change
-$0.83 (-3.40%)
Updated
Dec 18 closing price
GFACX
Price
$64.14
Change
-$8.99 (-12.29%)
Updated
Dec 18 closing price
Ad is loading...

BMCAX vs GFACX

Header iconBMCAX vs GFACX Comparison
Open Charts BMCAX vs GFACXBanner chart's image
BlackRock Advantage Large Cap Gr Inv A
Price$23.58
Change-$0.83 (-3.40%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer C
Price$64.14
Change-$8.99 (-12.29%)
VolumeN/A
CapitalizationN/A
BMCAX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BMCAX vs. GFACX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMCAX is a StrongBuy and GFACX is a Buy.

FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 313B vs. BMCAX (1.44B). BMCAX pays higher dividends than GFACX: BMCAX (0.04) vs GFACX (0.00). BMCAX was incepted earlier than GFACX: BMCAX (38 years) vs GFACX (24 years). BMCAX is a more actively managed with annual turnover of: 130.00 vs. GFACX (31.00). GFACX has a lower initial minimum investment than BMCAX: GFACX (250) vs BMCAX (1000). GFACX annual gain was more profitable for investors over the last year : 34.28 vs. BMCAX (12.70). BMCAX (48.88) and GFACX (47.11) have equivalent 5 years return.
BMCAXGFACXBMCAX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence38 years24 years-
Gain YTD11.97232.96436%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.44B313B0%
Annual Yield % from dividends0.040.00-
Returns for 1 year12.7034.2837%
Returns for 3 years11.7114.7180%
Returns for 5 years48.8847.11104%
Returns for 10 years76.6379.7796%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SWAG0.93N/A
+0.18%
Stran & Company
UTMD62.53-0.42
-0.67%
Utah Medical Products
RARE44.95-0.45
-0.99%
Ultragenyx Pharmaceutical
NWG10.23-0.20
-1.92%
NatWest Group plc
PFS20.19-0.47
-2.27%
Provident Financial Services